|
Volumn 54, Issue SUPPL. 3, 1997, Pages 83-89
|
Neuroprotective therapies in stroke
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
6,7 DICHLORO 5 NITRO 2,3 QUINOXALINEDIONE;
ALTEPLASE;
AMPA RECEPTOR ANTAGONIST;
APTIGANEL;
CITICOLINE;
FIBRINOLYTIC AGENT;
FOSPHENYTOIN SODIUM;
GLUTAMATE RECEPTOR ANTAGONIST;
GV 15026A;
LUBELUZOLE;
NALMEFENE;
NEUROPROTECTIVE AGENT;
SCAVENGER;
TIRILAZAD;
UNCLASSIFIED DRUG;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG TOLERABILITY;
FIBRINOLYTIC THERAPY;
HUMAN;
IMMUNOTHERAPY;
MAJOR CLINICAL STUDY;
META ANALYSIS;
NEUROLOGIC DISEASE;
NEUROPROTECTION;
STROKE;
TREATMENT OUTCOME;
ANIMALIA;
|
EID: 0030694565
PISSN: 00126667
EISSN: None
Source Type: Journal
DOI: 10.2165/00003495-199700543-00012 Document Type: Conference Paper |
Times cited : (33)
|
References (27)
|